FDA issues Medline bed alert with updated use and remedy instructions

Revision 1 · Medical device safety · United States · Record prepared

Prepared through Iliyn’s AI-assisted editorial workflow. Source statements are not independent audits of underlying events.

An FDA early alert covers all Medline Brand beds and associated components. Updated instructions allow continued use under specified conditions while repair or replacement is arranged.

What the record says

The FDA’s October 29 device update links an early alert about Medline Brand homecare, bariatric and long-term-care beds and associated components. The alert describes potential electrical fire and entrapment hazards.

Medline’s updated October 24 notice permits continued use according to modified instructions while a bed is repaired or replaced. FDA lists specific electrical-use precautions and warns against unauthorized repairs or modifications. Users and care facilities should read those complete instructions with the care team and supplier.

Certain beds may be repaired. Others may qualify for replacement or a full or partial refund, subject to Medline’s assessment. Products bought more than five years ago remain subject to the field action and updated instructions.

Source details and supporting locations.

Practical next step

Contact Medline Recall Customer Service at 800-950-0128, option 7, and review the FDA notice with the responsible care team.

Limits and what is not established

Do not infer universal refund eligibility or a blanket immediate removal instruction. Follow the product-specific, updated instructions and authorized remedy process.

Sources checked November 1, 2026. Later notices may change instructions or arrangements.

Original sources

U.S. Food and Drug Administration: original information

Corrections and history

Read correction history

Analytics is off unless you choose to accept. Privacy and contact